Organigram Holdings Inc. Files Final Base Shelf Prospectus
11 Outubro 2023 - 9:00PM
Business Wire
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the
“Company” or “Organigram”), a leading licenced
producer of cannabis, announced today that it has obtained a
receipt for a final short form base shelf prospectus (the “Base
Shelf Prospectus”) filed with the securities commissions in
each of the provinces and territories of Canada. A corresponding
shelf registration statement on Form F-10 (the “Registration
Statement”) has been filed with the United States Securities
and Exchange Commission (SEC File No. 333-274686) but is not yet
effective.
The Base Shelf Prospectus enables Organigram to qualify the
distribution of up to C$500,000,000 of common shares, debt
securities, subscription receipts, warrants, and units during the
25-month period that the Base Shelf Prospectus remains effective.
The specific terms of any future offering of securities will be
established in a prospectus supplement filed with the applicable
Canadian and US regulatory authorities. The Base Shelf Prospectus
will provide flexibility for financing options to pursue the
Company’s objectives.
A copy of the Base Shelf Prospectus can be found on SEDAR+ at
www.sedarplus.ca and a copy of the Registration Statement can be
found on EDGAR at www.sec.gov.
No offer to buy any securities of the Company can be accepted
until the Registration Statement has become effective.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and
TSX listed company whose wholly owned subsidiaries include:
Organigram Inc. a licensed producer of cannabis, cannabis-derived
products and cannabis infused edibles in Canada.
Organigram is focused on producing high-quality cannabis for
patients and adult recreational consumers, as well as developing
international business partnerships to extend the Company's global
footprint. Organigram has also developed and acquired a portfolio
of legal adult-use recreational cannabis brands, including Edison,
Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour,
Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates
facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec,
with a dedicated edibles manufacturing facility in Winnipeg,
Manitoba. The Company is regulated by the Cannabis Act and the
Cannabis Regulations (Canada).
Forward-Looking Information
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
factors and risks as disclosed in the Company’s most recent annual
information form, management’s discussion and analysis and other
Company documents filed from time to time on SEDAR+ (see
www.sedarplus.ca) and filed or furnished to the Securities and
Exchange Commission on EDGAR (see www.sec.gov). In addition, there
can be no assurance that Organigram will obtain a receipt
qualifying a final short form base shelf prospectus, that any
prospectus supplements will be filed, that any financings will be
completed under the short form base shelf prospectus, and that the
objectives sought from any financings will be fulfilled. Readers
are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
Although the Company believes that the assumptions and factors used
in preparing the forward-looking information in this news release
are reasonable, undue reliance should not be placed on such
information and no assurance can be given that such events will
occur in the disclosed time frames or at all. The forward-looking
information included in this news release are made as of the date
of this news release and the Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking information, whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231011671278/en/
For Investor Relations enquiries, please contact: Max Schwartz
Director of Investor Relations investors@organigram.ca Organigram
For Media enquiries, please contact: Megan McCrae Senior Vice
President of Marketing and Communications
megan.mccrae@organigram.ca Organigram
Organigram (NASDAQ:OGI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Organigram (NASDAQ:OGI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024